- Joined Nov 8, 2013
NVTA is gonna be a long term play for me. The use case is growing and societal benefit is there, whether or not the stock price will reflect that is always a question mark. Anecdotally, we use their gene test panels for BRCA testing and they are a huge part of prophylactic cancer screening. We’re still in early innings from my view for genetic testing as more doctors and hospital systems/insurance systems adopt genetic testing for personalized medicine, pregnancy, and cancer surveillance programs.Helped that I had a lot of realized gains to tax loss harvesting against. Nvta is probably a multibagger but I still don’t understand what they do so I’m going to focus on what I know.
Or just get in ARKG and ride the genomic wave without the individual concentration.